DRTS Reports $76.9M Cash, FDA Approves Prostate Trial, Launches Skin Cancer Module, Targets 5 U.S. Trials
Alpha Tau Medical Ltd. Ordinary Shares · Now $9.66
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS